Dashboard
Manage Tickers

AZNCFASTRAZENECA PLC

Nasdaq astrazeneca.com


$ -1.14 (-0.72 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.21 $ -2.76 (-0.58 %)
DIA $ 416.64 $ -1.35 (-0.32 %)
SPY $ 562.54 $ -2.59 (-0.46 %)
TLT $ 100.96 $ -0.43 (-0.42 %)
GLD $ 237.01 $ -0.97 (-0.41 %)
$ 157
-- x --
-- x --
-- - --
$ 115.61 - $ 175.00
948
na
122.53B
$ 0.42
$ 7.16
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
China's National Medical Products Associat...
08/20/2024 08:58:34

Core News & Articles
FDA Approves AstraZeneca's Imfinzi (Durval...
08/16/2024 09:18:09

Core News & Articles
The FDA Has Accepted Under Priority Review...
08/15/2024 08:55:40

Core News & Articles
The European Union Has Approved AstraZenec...
08/14/2024 09:42:34

Imfinzi plus chemotherapy as 1st-line treatment followed by Lynparza and Imfinzi has been approved for patients with mismatch r...

Core News & Articles
AstraZeneca And Sanofi's Beyfortus (Nirsev...
01/02/2024 08:29:02

Beyfortus is anticipated to be available during the upcoming 2024-2025 RSV season.  

Core News & Articles
China Approves AstraZeneca's Imfinzi (Durv...
11/14/2023 09:53:47

Core News & Articles
AztraZeneca's Tagrisso Plus Chemotherapy E...
09/11/2023 08:31:40

The trial included patients with locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) epidermal growth factor receptor-m...

Core News & Articles
AstraZeneca, Daiichi Sankyo's Datopotamab ...
09/11/2023 08:29:44

The trial included patients with previously untreated advanced or metastatic non-small cell lung cancer (NSCLC) without actiona...

Core News & Articles
The FDA Issued A Complete Response Letter ...
09/06/2023 08:24:25

The CRL did not request additional analysis or reanalysis of the Phase 3 CHAMPION-NMOSD trial data and did not raise concerns...

astrazeneca-abandons-blood-cancer-cardiovascular-programs-amid-portfolio-prioritization
AstraZeneca Abandons Blood Cancer, Cardiov...
07/28/2023 17:51:17

Earlier today, AstraZeneca plc (NASDAQ: AZN) 

astrazeneca-q2-earnings-beat-consensus-despite-zero-covid-19-vaccine-sales-stock-shoots-up
AstraZeneca Q2 Earnings Beat Consensus Des...
07/28/2023 12:46:39

AstraZeneca Plc's (NASDAQ: AZN) unit Alexion has 

Core News & Articles
Ionis Has Expanded Its Existing Collaborat...
07/28/2023 11:08:39

Ionis and AstraZeneca will continue to jointly develop and commercialize eplontersen in the U.S. The companies are successfully...

Core News & Articles
Alexion, AstraZeneca Rare Disease Agreed T...
07/28/2023 07:35:25

https://www.astrazeneca.com/media-centre/press-releases/2023/alexion-enters-gene-therapy-agreement-with-pfizer.html

Core News & Articles
AstraZeneca's Soliris (Eculizumab) Has Bee...
07/27/2023 08:15:42

astrazeneca-sanofis-respiratory-syncytial-virus-treatment-scores-fda-approval-to-prevent-infection-in-infants
AstraZeneca-Sanofi's Respiratory Syncytial...
07/18/2023 13:07:02

The FDA approved AstraZeneca Plc (NASDAQ:

astrazeneca-shares-under-pressure-on-some-adverse-events-in-late-stage-lung-cancer-drug-trial
AstraZeneca Shares Under Pressure On Some ...
07/03/2023 09:50:08

AstraZeneca Plc (NASDAQ: AZN) reported high-level results from the TROPION-Lung01 Phase 3 trial of datopotamab deruxtecan (Dato...

astrazenecas-imfinziimjudo-combo-shows-sustained-overall-survival-benefit-at-four-years-in-liver-cancer
AstraZeneca's Imfinzi/Imjudo Combo Shows S...
06/29/2023 17:39:45

AstraZeneca Plc (NASDAQ: AZN) released updated results from the HIMALAYA Phase 3 trial evaluating Imfinzi (durvalumab) plus Imj...

astrazeneca-seeks-expanded-use-for-soliris-as-first-targeted-therapy-for-pediatric-patients-with-autoimmune-neuromuscular-disease
AstraZeneca Seeks Expanded Use For Soliris...
06/26/2023 12:28:58

The European Union has reco

why-are-pieris-pharmaceuticals-shares-tanking-today
Why Are Pieris Pharmaceuticals Shares Tank...
06/21/2023 13:41:04

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) announced that partner AstraZeneca plc (NASDAQ: AZN) decided to discontinue and cease...

astrazeneca-mulls-china-business-unit-spin-off-amid-geopolitical-tensions
AstraZeneca Mulls China Business Unit Spin...
06/20/2023 12:23:28

European drugmaker AstraZeneca plc (NASDAQ: AZN) is reportedly drafting a plan to spin off its China business, and listing a se...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION